Skip to main navigation

Overview
News & Events
- News Releases
- Events
Corporate Governance
Stock Information
- Stock Quote & Chart
- Historic Price Lookup
Financial Information
- SEC Filings
IR Resources

News Releases

Year

22 Dec '22

SeqLL Inc. Granted Second 180-day Extension by Nasdaq Regarding Minimum Bid Requirements

13 Dec '22

Brian Paras joins SeqLL as Chief Business Officer

09 Nov '22

SeqLL Provides Third Quarter 2022 Financial Results

13 Sep '22

UPDATE -- SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology

12 Sep '22

SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology

06 Sep '22

SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

24 Jun '22

SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

13 Jun '22

SeqLL’s Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal

13 May '22

SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update

30 Mar '22

SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

Current page 1
Page 2
Next page

Displaying 1 - 10 of 12

Featured Pages

stock Information

Information Request

Financial Information

Investor Tools

Print Page
Email Alerts
Search

Request Email Alerts

© 2023 SeqLL Inc. All rights reserved.

Facebook
Twitter
LinkedIn
Google+